Post by Algaurizin

The S&P 500 Just Locked Out AI Unicorns, Healthcare Is Secretly Winning OpenAI lost $14B on $11.9B revenue. Anthropic crossed $30B revenue but remains unprofitable. SpaceX is profitable... but blocked until June 2027. The S&P 500's GAAP profitability rule didn't just exclude AI unicorns. It validated what healthcare has been doing for decades. Let me show you what major outlets aren't highlighting: The In-Depth Healthcare Impact 1. Healthcare Is the Only Sector That Wins BOTH Ways - 89% of S&P 500 healthcare companies exceeded earnings in 2025 (2nd among all sectors) - Yet healthcare has low correlation to AI, making it the perfect defensive counterbalance - When AI burns cash, healthcare delivers predictable returns This means: Healthcare investors are gaining from the AI boom (through partnerships with Microsoft, Nvidia, Amazon) while avoiding the AI risk (unprofitable unicorns excluded from S&P 500). 2. FDA Policy Changes = AI Acceleration in Healthcare The profitability rule filters for companies with sustainable business models. Healthcare AI is already proving this: - FDA cleared 331 AI devices in 2025, vs. just 6 in 2015 (55-fold increase) - 1,394 cumulative AI/ML devices authorized since 2015 - 77% of clearances are in radiology/diagnostics, AI's natural fit for pattern recognition Last year was a turning point: FDA allowed computer-based alternatives to animal testing (April), rolled back lab-developed test oversight (September), and the DOE got directed to build unified AI platform for biotech breakthroughs (November). 3. Capital Flows to Profitable Healthcare Incumbents, Not Unprofitable AI The S&P rule forces capital toward profitable incumbents. Healthcare is the prototype: - 30-year earnings growth: 9% vs. 5-year average of 15% - Earnings acceleration expected in 2027 (pharma + managed care) - Valuations are low with room to grow — positive earnings surprise suggests demand is stronger than market acknowledges 4. The Real Gap: Private vs. Public Healthcare AI Expectations Healthcare AI companies hitting $100M-$200M ARR in under 5 years (vs. 10+ years for traditional healthcare software) now face the S&P profitability filter. This creates: - A widening gap between private market hype and public market reality - Healthcare AI must prove GAAP profitability, not just revenue run rates - The "growth-at-all-costs" model is dying, "durable earnings" is winning Why Healthcare Is Secretly Winning When the S&P holds the line on GAAP earnings, healthcare wins because: ✅ It's already profitable (89% beat earnings)   ✅ It's seeing tangible AI benefits (331 AI devices cleared in 2025)   ✅ It's defensive (low correlation to tech/AI)   ✅ It's undervalued (trading at discount to tech)   ✅ It's accelerating (2027 earnings growth expected) The S&P locked out AI unicorns. Healthcare is the quiet winning Drop your take below #AI #GAAP #FDA